Qureight secures $20M Series B funding to scale its AI respiratory imaging platform. The fresh capital will accelerate global expansion and clinical trial infrastructure for lung and heart disease diagnostics. The platform uses specialized machine learning models to analyze complex medical scans, helping biopharma developers streamline trial endpoints and reduce analysis time.
Opening Kapyn…